Fatty-acid-based antimiR-23b delivery in the DMSXL model: A potential therapeutic strategy for brain dysfunction in myotonic dystrophy type 1. (linkinghub.elsevier.com)

Authors: Piqueras-Losilla D … Cerro-Herreros E Journal: Cell Reports Medicine Published: 2026-07-22 DOI: https://doi.org/10.1016/j.xcrm.2026.102929